UTI AMC Intrinsic Value
UTI AMC (UTIAMC) median intrinsic value is ₹349.22 from 3 valuation models (range ₹286–₹564), vs current price ₹954.50 — -63.4% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit UTIAMC share price.
UTIAMC Valuation Methods Summary — DCF, Graham Number & P/E
UTI AMC intrinsic value across 3 models vs current price ₹954.50 — upside/downside and value range per method. Also explore UTI AMC stock price data download to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹349.22 | ₹314.30 - ₹384.14 | -63.4% | Book Value/Share: ₹349.22, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹286.35 | ₹257.72 - ₹314.99 | -70.0% | Revenue/Share: ₹124.65, P/S: 0.8x |
| Simple DCF (5Y) | dcf | ₹564.39 | ₹451.51 - ₹677.27 | -40.9% | CF Growth: 15.0%, Discount: 15% |
UTIAMC Intrinsic Value vs Market Price — All Valuation Models
UTI AMC fair value range ₹286–₹564 vs current market price ₹954.50 across 3 valuation models. Read UTIAMC ex-dividend dates for the complete payout history and dividend yield track record.
UTIAMC Intrinsic Value Analysis — Undervalued or Overvalued?
UTI AMC median intrinsic value ₹349.22, current price ₹954.50 — Trading Above Calculated Value by 63.4%, margin of safety -100.0%.
What is the intrinsic value of UTIAMC?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of UTI AMC (UTIAMC) is ₹349.22 (median value). With the current market price of ₹954.50, this represents a -63.4% variance from our estimated fair value.
The valuation range spans from ₹286.35 to ₹564.39, indicating ₹286.35 - ₹564.39.
Is UTIAMC undervalued or overvalued?
Based on our multi-method analysis, UTI AMC (UTIAMC) appears to be trading above calculated value by approximately 63.4%.
UTIAMC Financial Health — Key Ratios vs Industry Benchmarks
UTI AMC financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.85 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -4.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -3.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.32x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
UTIAMC Cash Flow Quality — Operating & Free Cash Flow
UTI AMC operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹536 Cr | ₹536 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹325 Cr | ₹252 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹395 Cr | ₹349 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹337 Cr | ₹307 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹153 Cr | ₹125 Cr | Positive Free Cash Flow | 8/10 |